共 50 条
The community pharmacy model for colorectal cancer screening: Policy insights from a national programme
被引:2
|作者:
Della Valle, P. G.
[1
]
Deandrea, S.
[1
,2
,3
,9
]
Battisti, F.
[4
]
Brusa, P.
[5
]
Mantellini, P.
[4
]
Mantovani, W.
[6
]
Narne, E.
[7
]
Odone, A.
[1
]
Senore, C.
[8
]
机构:
[1] Univ Pavia, Pavia, Italy
[2] Pavia Hlth Protect Agcy, Pavia, Italy
[3] Directorate Gen Hlth, Milan, Lombardy, Italy
[4] Ist Studio, Prevenz & Rete Oncolog, Florence, Italy
[5] Univ Studi Torino, Dipartimento Sci & Tecnol Farmaco, Turin, Italy
[6] Azienda Provinciale Servizi Sanitari Trento, Trento, Italy
[7] Azienda Zero, Padua, Italy
[8] AOU Citt Salute & Sci Torino, Turin, Italy
[9] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Pavia, Italy
来源:
关键词:
Screening;
Community pharmacy;
Colorectal cancer;
National screening programme;
D O I:
10.1016/j.sapharm.2023.08.009
中图分类号:
R1 [预防医学、卫生学];
学科分类号:
1004 ;
120402 ;
摘要:
Background: In Italy, a recent national project has expanded local collaboration between colorectal (CRC) screening programmes and pharmacies to the national level. Objective: The objective of this study is to provide an overview of the existing agreements between regional authorities and pharmacy owners in Italy regarding CRC screening programmes, to make internationally available the most qualifying elements of the collaboration.Methods: We analyzed the agreements, in force on 01/08/2021, arranged between the Regions and their respective pharmacy owners, describing the process phases addressed such as the faecal occult blood test pathway and supplementary activities provided by the pharmacies together with the CRC screening kit delivery. Results: Agreements were received from 18 Regions (86% of the total). The amount of money paid for each kit varies a lot, with a range from 0 to 18 EUR. The number of process phases covered by the agreements ranged from a maximum of 16 (out of 18) to a minimum of 0. The processes most frequently covered were the supply/ delivery of kits and education/awareness of CRC screening (68.8%). Less covered processes were warehouse management and awareness of other healthcare initiatives (12.5%), and delivery of preparation for intestinal cleansing (6.3%).Conclusions: Arrangements between pharmacies and CRC screening programmes in Italy vary widely and lack a unified model. Collaboration quality standards should be set at the national/international level.
引用
收藏
页码:1595 / 1601
页数:7
相关论文